Sign Up
Stories
ARCA Biopharma Revenue Insights
Share
ADR Surge and Drops in NY
Akari Therapeutics: Merger and Progress
Arcus Biosciences Boosts Inducement Gran...
ABIO ARCA Revenue Analysis
ARCA Biopharma Revenue Insights
Amgen's Weight-Loss Drugs Market Entranc...
Overview
API
ABIO ARCA biopharma reports revenue breakdown with Callida generating $612K and Nuvelo $54K. The stock boasts a P/E ratio of 14.50 and a dividend yield of 5.14%.
Ask a question
How does the P/E ratio and dividend yield reflect ARCA Biopharma's financial health and growth potential?
How might the revenue breakdown influence investor sentiment towards ARCA Biopharma?
What strategies could ARCA Biopharma employ to enhance the revenue streams of Nuvelo?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Dec 2023
Jan 2024
Feb 2024
Coverage
moomo